Stocks and Investing
Stocks and Investing
Wed, May 15, 2024
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
Douglas Tsao Maintained (aeon) at Strong Buy with Decreased Target to $6 on, May 15th, 2024
Douglas Tsao of HC Wainwright & Co., Maintained "AEON Biopharma, Inc." (AEON) at Strong Buy with Decreased Target from $18 to $6 on, May 15th, 2024.
Douglas, nor any peers, have made any analyst calls on AEON in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources